Search Results - "Beste, Lauren A."

Trends in Burden of Cirrhosis and Hepatocellular Carcinoma by Underlying Liver Disease in US Veterans, 2001–2013 by Beste, Lauren A, Leipertz, Steven L, Green, Pamela K, Dominitz, Jason A, Ross, David, Ioannou, George N

“…Background & Aims Cirrhosis and hepatocellular carcinoma (HCC) are predicted to increase in the United States but the accuracy of prior forecasts and the…”
Get full text

Hepatitis C–Related Hepatocellular Carcinoma Incidence in the Veterans Health Administration After Introduction of Direct-Acting Antivirals by Beste, Lauren A, Green, Pamela, Berry, Kristin, Belperio, Pamela, Ioannou, George N

“…This study describes trends in the incidence of hepatocellular carcinoma within the Veterans Health Administration from 2002 to 2018 before and after…”
Get full text

Machine learning models to predict disease progression among veterans with hepatitis C virus by Konerman, Monica A, Beste, Lauren A, Van, Tony, Liu, Boang, Zhang, Xuefei, Zhu, Ji, Saini, Sameer D, Su, Grace L, Nallamothu, Brahmajee K, Ioannou, George N, Waljee, Akbar K

“…Machine learning (ML) algorithms provide effective ways to build prediction models using longitudinal information given their capacity to incorporate numerous…”
Get full text

Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients by Su, Feng, Beste, Lauren A, Green, Pamela K, Berry, Kristin, Ioannou, George N

“…BACKGROUNDThe mean age of patients with chronic hepatitis C virus (HCV) infection in the USA has been increasing. Despite the increasing proportion of…”
Get full text

Telemedicine specialty support promotes hepatitis c treatment by primary care providers in the Department of Veterans Affairs by Beste, Lauren A., MD, MSc, Glorioso, Thomas J., MS, Ho, P. Michael, MD, Au, David H., MD, MS, Kirsh, Susan R., MD, MPH, Todd-Stenberg, Jeffrey, BA, Chang, Michael F., MD, MPH, Dominitz, Jason A., MD, MHS, Barón, Anna E., PhD, Ross, David, MD, PhD

“…Abstract Background & Aims The Department of Veterans Affairs (VA) is the largest US provider of hepatitis c treatment. Although antiviral regimens are…”
Get full text

The Impact of Insulin Resistance on Hepatic Fibrosis among United States Adults with Non-Alcoholic Fatty Liver Disease: NHANES 2017 to 2018 by Bae, Ji Cheol, Beste, Lauren A., Utzschneider, Kristina M.

“…Background: We aimed to investigate the association of hepatic steatosis with liver fibrosis and to assess the interactive effects of hepatic steatosis and…”
Get full text

Brief communication: The cohort of women prescribed HIV PrEP at the Veterans Health Administration by Keddem, Shimrit, Broderick, Kaitlyn, Van Epps, Puja, Roberts, Christopher B, Chhatre, Sumedha, Beste, Lauren A

“…Abstract The goal of this study was to describe the cohort of women prescribed PrEP at the Veterans Health Administration. We used a cross-sectional study of…”
Get full text

Associations of statin use with 30-day adverse outcomes among 4 801 406 US Veterans with and without SARS-CoV-2: an observational cohort study by Wander, Pandora L, Lowy, Elliott, Beste, Lauren A, Tulloch-Palomino, Luis, Korpak, Anna, Peterson, Alexander C, Kahn, Steven E, Danaei, Goodarz, Boyko, Edward J

“…ObjectiveTo estimate associations of statin use with hospitalisation, intensive care unit (ICU) admission and mortality at 30 days among individuals with and…”
Get full text

Adapted time-varying covariates Cox model for predicting future cirrhosis development performs well in a large hepatitis C cohort by Beste, Lauren A, Zhang, Xuefei, Su, Grace L, Van, Tony, Ioannou, George N, Oselio, Brandon, Tincopa, Monica, Liu, Boang, Singal, Amit G, Zhu, Ji, Waljee, Akbar K

“…Patients with hepatitis C virus (HCV) frequently remain at risk for cirrhosis after sustained virologic response (SVR). Existing cirrhosis predictive models…”
Get full text

Risk factors for adverse outcomes among 35 879 veterans with and without diabetes after diagnosis with COVID-19 by Wander, Pandora L, Lowy, Elliott, Beste, Lauren A, Tulloch-Palomino, Luis, Korpak, Anna, Peterson, Alexander C, Young, Bessie A, Boyko, Edward J

“…IntroductionRisk factors and mediators of associations of diabetes with COVID-19 outcomes are unclear.Research design and methodsWe identified all veterans…”
Get full text

Eliciting patient views on the allocation of limited healthcare resources: a deliberation on hepatitis C treatment in the Veterans Health Administration by Waljee, Akbar K, Ryan, Kerry A, Krenz, Chris D, Ioannou, George N, Beste, Lauren A, Tincopa, Monica A, Saini, Sameer D, Su, Grace L, Arasim, Maria E, Roman, Patti T, Nallamothu, Brahmajee K, De Vries, Raymond

“…In response to the development of highly effective but expensive new medications, policymakers, payors, and health systems are considering novel and pragmatic…”
Get full text

Alcohol Screening and Risk of Postoperative Complications in Male VA Patients Undergoing Major Non-cardiac Surgery by Bradley, Katharine A., Rubinsky, Anna D., Sun, Haili, Bryson, Chris L., Bishop, Michael J., Blough, David K., Henderson, William G., Maynard, Charles, Hawn, Mary T., Tønnesen, Hanne, Hughes, Grant, Beste, Lauren A., Harris, Alex H. S., Hawkins, Eric J., Houston, Thomas K., Kivlahan, Daniel R.

“…ABSTRACT BACKGROUND Patients who misuse alcohol are at increased risk for surgical complications. Four weeks of preoperative abstinence decreases the risk of…”
Get full text

SARS-CoV-2 infection is associated with higher odds of insulin treatment but not with hemoglobin A1c at 120 days in U.S. Veterans with new-onset diabetes by Wander, Pandora L., Lowy, Elliott, Korpak, Anna, Beste, Lauren A., Kahn, Steven E., Boyko, Edward J.

“…To examine associations of SARS-CoV-2 infection/COVID-19 with insulin treatment in new-onset diabetes. We conducted a retrospective cohort study using Veterans…”
Get full text

Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration by Hunt, Christine M, Beste, Lauren A, Lowy, Elliott, Suzuki, Ayako, Moylan, Cynthia A, Tillmann, Hans L, Ioannou, George N, Lim, Joseph K, Kelley, Michael J, Provenzale, Dawn

“…AIM: To evaluate pretreatment hepatitis B virus(HBV) testing, vaccination, and antiviral treatment rates in Veterans Affairs patients receiving anti-CD20 Ab…”
Get full text

Implementation of a novel population panel management curriculum among interprofessional health care trainees by Kaminetzky, Catherine P, Beste, Lauren A, Poppe, Anne P, Doan, Daniel B, Mun, Howard K, Woods, Nancy Fugate, Wipf, Joyce E

“…Gaps in chronic disease management have led to calls for novel methods of interprofessional, team-based care. Population panel management (PPM), the process of…”
Get full text

Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores by Ioannou, George N., Beste, Lauren A., Green, Pamela K., Singal, Amit G., Tapper, Elliot B., Waljee, Akbar K., Sterling, Richard K., Feld, Jordan J., Kaplan, David E., Taddei, Tamar H., Berry, Kristin

“…It is unclear if hepatocellular carcinoma (HCC) risk declines over time after hepatitis C virus (HCV) eradication. We analyzed changes in HCC annual incidence…”
Get full text

AUDIT-C Alcohol Screening Results and Postoperative Inpatient Health Care Use by Rubinsky, Anna D., MS, Sun, Haili, PhD, Blough, David K., PhD, Maynard, Charles, PhD, Bryson, Christopher L., MD, MS, Harris, Alex H., PhD, Hawkins, Eric J., PhD, Beste, Lauren A., MD, MS, Henderson, William G., PhD, Hawn, Mary T., MD, MPH, FACS, Hughes, Grant, BS, Bishop, Michael J., MD, Etzioni, Ruth, PhD, Tønnesen, Hanne, MD, DMSc, Kivlahan, Daniel R., PhD, Bradley, Katharine A., MD, MPH

“…Background Alcohol screening scores ≥5 on the Alcohol Use Disorders Identification Test–Consumption (AUDIT-C) up to a year before surgery have been associated…”
Get full text

Prevalence and Management of Chronic Hepatitis C Virus Infection in Women by Beste, Lauren A., MD, MSc, Bondurant, Hollye C., PharmD, Ioannou, George N., BMBCh, MS

“…Hepatitis C virus (HCV) is the most common blood-borne pathogen in the United States and is a leading cause of cirrhosis, need for liver transplantation, and…”
Get full text

Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System by Ioannou, George N, Beste, Lauren A, Chang, Michael F, Green, Pamela K, Lowey, Elliot, Tsui, Judith I, Su, Feng, Berry, Kristin

“…Background & Aims We investigated the real-world effectiveness of sofosbuvir, ledipasvir/sofosbuvir, and paritaprevir/ritonavir/ombitasvir and dasabuvir (PrOD)…”
Get full text

Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C by Ioannou, George N., Green, Pamela K., Beste, Lauren A., Mun, Elijah J., Kerr, Kathleen F., Berry, Kristin

“…[Display omitted] •We developed and validated models to estimate HCC risk after antiviral treatment for HCV.•Using these models may improve HCC screening…”
Get full text